Revvity, MPSU-PTRET-K-HV, AlphaLISA SureFire Ultra Multiplex Human and Mouse Phospho-RET (Pan-Tyr & total) Detection Kit, 100 Assay Points

Overview
Rearranged during transfection (RET or c-RET) is a receptor tyrosine kinase primarily expressed as two isoforms of 1072 & 1114 amino acids. RET activation by glial cell line-derived neurotrophic family ligands (GFL) leads to its dimerization and autophosphorylation on intracellular tyrosine residues. RET is required for the development of the nervous system and several other tissues. RET alterations have been detected in numerous human cancers. The development of highly selective and potent RET kinase inhibitors is therefore of great interest to treat RET-altered cancers.
The AlphaLISA SureFire Ultra Multiplex Human and Mouse Phospho-RET (panTyr)/Total RET Detection Kit is used to measure both phosphorylated and total levels of endogenous RET in cellular lysates in a multiplexing Alpha no-wash assay. No specially engineered cell lines are required. The 615 nm (Eu) signal corresponds to the phosphorylated RET analysis, and the 545 nm (Tb) signal corresponds to the total RET analysis. This kit has been formulated to provide superior signal:background assay windows and to perform without interference in the presence of extraneous antibodies, making it amenable to the study of therapeutic and blocking antibodies.

No-wash steps, no separation steps
Multiplexing assay
Sensitive detection
No interference from exogenous antibodies
Results in less than 3 hours

In this assay, the Alpha 615 Acceptor bead is coated with the CaptSure™ antibody, which binds the CaptSure-tagged anti-phospho target antibody. The Alpha 545 Acceptor bead is coated with the CaptSure2™ agent, which binds the CaptSure2 tagged anti-total target protein antibody. The Alpha Donor bead binds the biotinylated anti-total target protein antibody.
How it works
Multiplex SureFire Ultra assay principle
The Multiplex SureFire Ultra assay simultaneously measures phospho and total protein at specific levels. It utilizes three antibodies that recognize the phospho epitope and two distal epitopes on the target protein. The assay requires three bead types: two distinct acceptor beads and one donor bead.

The Alpha 615 acceptor bead is coated with the CaptSure™ antibody, which binds the CaptSure-tagged anti-phospho target antibody.
The Alpha 545 acceptor bead is coated with the CaptSure2 antibody, which binds the CaptSure2-tagged anti-total target protein antibody.
The Alpha donor bead binds the biotinylated anti-total target protein antibody.

When the phosphorylated protein is present, the three antibodies bring the donor and acceptor beads close together, allowing singlet oxygen to transfer energy and excite both acceptor beads. This generates a luminescent Alpha signal at 615nm and 545nm. The 615nm (Eu) signal is directly proportional to the amount of phosphorylated protein, while the 545nm (Tb) signal corresponds to the total protein levels.

Multiplex SureFire Ultra two-plate assay protocol
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well Optiplate™ plate before the addition of Multiplex SureFire Ultra detection reagents. This protocol enables the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure different targets.

Multiplex SureFire Ultra one-plate assay protocol
Detection of phosphorylated/total target proteins with Multiplex SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust AlphaLISA SureFire Ultra quality. Application-Cell Signaling
Automation Compatible-Yes
Brand-AlphaLISA SureFire Ultra Multiplex
Detection Modality-Alpha
Lysis Buffer Compatibility-Lysis Buffer
Molecular Modification-Phosphorylation
Product Group-Kit
Sample Volume-30 µL
Shipping Conditions-Shipped in Blue Ice
Target-RET
Target Class-Phosphoproteins
Target Species-Human
Technology-Alpha
Therapeutic Area-Oncology
Unit Size-100 assay points